SPC472
Adagrasíb eða lyfjafræðilega viðunandi salt þar af
:
Umsókn:
11.6.2024:
15.7.2024
:
8.1.2039:
Krazati
11.6.2024
15.7.2024
8.1.2039
:
EU/1/23/1744:
12.1.2024
:
EU/1/23/1744:
5.1.2024
:
Mirati Therapeutics, Inc.:
Route 206 and Province Line Road, Princeton, New Jersey 08543 US
:
Array Biopharma Inc.:
3200 Walnut Street, Boulder, CO 80301 US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113 Reykjavík